Verified factor-similar pair

CSB vs SMDV

These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.

SMB HML RMW
Similarity score
81
Verified similar

The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.

Quick Read

  • SMDV has the higher backtested relative Sharpe (1.252 vs 1.125).
  • SMDV is cheaper on dividend valuation (97 vs 134, where 100 is each fund's historical median).
  • CSB has the stronger regression fit (adjusted R-squared 0.949 vs 0.810).

These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.

CSB

VictoryShares US Small Cap High Dividend Volatility Wtd ETF
SMB HML RMW
Adj. R2
0.949
Rel. Sharpe
1.125
Mkt beta
0.81
AUM
US$261M
MER
0.40%
Valuation
134

SMDV

ProShares Russell 2000 Dividend Growers ETF
SMB HML RMW
Adj. R2
0.810
Rel. Sharpe
1.252
Mkt beta
0.67
AUM
US$659M
MER
0.40%
Valuation
97

Factor Exposure Match

Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.

SMB
CSB
+0.81
|t|
+16.8
SMDV
+0.67
|t|
+9.0
diff +0.13
HML
CSB
+0.35
|t|
+8.3
SMDV
+0.32
|t|
+4.6
diff +0.04
RMW
CSB
+0.35
|t|
+6.7
SMDV
+0.27
|t|
+3.2
diff +0.08
CMA
CSB
+0.04
|t|
+0.7
SMDV
+0.04
|t|
+0.4
diff -0.00
UMD
CSB
-0.05
|t|
-1.5
SMDV
+0.08
|t|
+1.6
diff -0.13

Why This Pair Matches

Exposure level
78
Exposure shape
99
Mkt beta diff
0.14
Rel. Sharpe diff
0.127

This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.

CSB fund page SMDV fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.